R21/Matrix M™ (Group 2) clinical trials

A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

This study is testing a new malaria vaccine, R21/Matrix-M™, in healthy adults who've never had malaria. We want to see how safe it is and how well their bodies learn to fight off the disease after getting the vaccine, using different dose schedules.